Metformin and COVID-19: From cellular mechanisms to reduced mortality

DOI record: { "DOI": "10.1016/j.diabet.2020.07.006", "ISSN": [ "1262-3636" ], "URL": "http://dx.doi.org/10.1016/j.diabet.2020.07.006", "alternative-id": [ "S1262363620300987" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Metformin and COVID-19: From cellular mechanisms to reduced mortality" }, { "label": "Journal Title", "name": "journaltitle", "value": "Diabetes & Metabolism" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.diabet.2020.07.006" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2020 Elsevier Masson SAS. All rights reserved." } ], "author": [ { "affiliation": [], "family": "Scheen", "given": "A.J.", "sequence": "first" } ], "container-title": "Diabetes & Metabolism", "container-title-short": "Diabetes & Metabolism", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.fr", "clinicalkey.com.au", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2020, 8, 1 ] ], "date-time": "2020-08-01T20:07:46Z", "timestamp": 1596312466000 }, "deposited": { "date-parts": [ [ 2021, 3, 27 ] ], "date-time": "2021-03-27T14:06:12Z", "timestamp": 1616853972000 }, "indexed": { "date-parts": [ [ 2024, 4, 23 ] ], "date-time": "2024-04-23T09:57:05Z", "timestamp": 1713866225553 }, "is-referenced-by-count": 133, "issue": "6", "issued": { "date-parts": [ [ 2020, 11 ] ] }, "journal-issue": { "issue": "6", "published-print": { "date-parts": [ [ 2020, 11 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 11, 1 ] ], "date-time": "2020-11-01T00:00:00Z", "timestamp": 1604188800000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S1262363620300987?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S1262363620300987?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "423-426", "prefix": "10.1016", "published": { "date-parts": [ [ 2020, 11 ] ] }, "published-print": { "date-parts": [ [ 2020, 11 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1016/j.diabet.2020.05.001", "article-title": "Patients with diabetes are at higher risk for severe illness from COVID-19", "author": "Targher", "doi-asserted-by": "crossref", "journal-title": "Diabetes Metab", "key": "10.1016/j.diabet.2020.07.006_bib0005", "year": "2020" }, { "article-title": "Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: a narrative review", "author": "Kumar Singh", "journal-title": "Diabetes Res Clin Pract", "key": "10.1016/j.diabet.2020.07.006_bib0010", "volume": "165", "year": "2020" }, { "DOI": "10.1016/j.dsx.2020.04.044", "article-title": "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis", "author": "Kumar", "doi-asserted-by": "crossref", "first-page": "535", "journal-title": "Diabetes Metab Syndr", "key": "10.1016/j.diabet.2020.07.006_bib0015", "volume": "14", "year": "2020" }, { "DOI": "10.1007/s00125-020-05180-x", "article-title": "Phenotypic characteristics and prognosis of in-patients with COVID-19 and diabetes: the CORONADO study", "author": "Cariou", "doi-asserted-by": "crossref", "first-page": "1500", "journal-title": "Diabetologia", "key": "10.1016/j.diabet.2020.07.006_bib0020", "volume": "63", "year": "2020" }, { "DOI": "10.1016/j.diabres.2020.108186", "article-title": "Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory", "author": "Ceriello", "doi-asserted-by": "crossref", "journal-title": "Diabetes Res Clin Pract", "key": "10.1016/j.diabet.2020.07.006_bib0025", "volume": "163", "year": "2020" }, { "article-title": "Why is hyperglycemia worsening COVID-19 and its prognosis?", "author": "Ceriello", "journal-title": "Diabetes Obes Metab", "key": "10.1016/j.diabet.2020.07.006_bib0030", "volume": "28", "year": "2020" }, { "DOI": "10.1016/j.diabres.2020.108146", "article-title": "Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?", "author": "Pal", "doi-asserted-by": "crossref", "journal-title": "Diabetes Res Clin Pract", "key": "10.1016/j.diabet.2020.07.006_bib0035", "volume": "163", "year": "2020" }, { "DOI": "10.1111/1753-0407.13047", "article-title": "Is the type of diabetes treatment relevant to outcome of COVID-19?", "author": "Bloomgarden", "doi-asserted-by": "crossref", "first-page": "486", "journal-title": "J Diabetes", "key": "10.1016/j.diabet.2020.07.006_bib0040", "volume": "12", "year": "2020" }, { "DOI": "10.1007/s00125-019-05039-w", "article-title": "2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)", "author": "Buse", "doi-asserted-by": "crossref", "first-page": "221", "journal-title": "Diabetologia", "key": "10.1016/j.diabet.2020.07.006_bib0045", "volume": "63", "year": "2020" }, { "DOI": "10.1016/S0140-6736(98)07037-8", "article-title": "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), UK Prospective Diabetes Study (UKPDS) Group", "author": "United Kingdom Prospective Diabetes Study Group", "doi-asserted-by": "crossref", "first-page": "854", "journal-title": "Lancet", "key": "10.1016/j.diabet.2020.07.006_bib0050", "volume": "352", "year": "1998" }, { "DOI": "10.1016/j.diabet.2020.05.008", "article-title": "Prognostic factors in patients with diabetes hospitalized for COVID-19: findings from the CORONADO study and recent reports", "author": "Scheen", "doi-asserted-by": "crossref", "journal-title": "Diabetes Metab", "key": "10.1016/j.diabet.2020.07.006_bib0055", "year": "2020" }, { "DOI": "10.1111/dom.14134", "article-title": "Diabetes, obesity and COVID-19: a complex interplay", "author": "Vas", "doi-asserted-by": "crossref", "journal-title": "Diabetes Obes Metab", "key": "10.1016/j.diabet.2020.07.006_bib0060", "year": "2020" }, { "DOI": "10.1152/ajpendo.00124.2020", "article-title": "COVID-19 pandemic, coronaviruses, and diabetes mellitus", "author": "Muniyappa", "doi-asserted-by": "crossref", "first-page": "E736", "journal-title": "Am J Physiol Endocrinol Metab", "key": "10.1016/j.diabet.2020.07.006_bib0065", "volume": "318", "year": "2020" }, { "DOI": "10.1161/CIRCRESAHA.116.308445", "article-title": "Anti-inflammatory effects of metformin irrespective of diabetes status", "author": "Cameron", "doi-asserted-by": "crossref", "first-page": "652", "journal-title": "Circ Res", "key": "10.1016/j.diabet.2020.07.006_bib0070", "volume": "119", "year": "2016" }, { "DOI": "10.1016/S2213-8587(20)30021-8", "article-title": "Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial", "author": "Pernicova", "doi-asserted-by": "crossref", "first-page": "278", "journal-title": "Lancet Diabetes Endocrinol", "key": "10.1016/j.diabet.2020.07.006_bib0075", "volume": "8", "year": "2020" }, { "DOI": "10.1007/s13300-020-00830-0", "article-title": "COVID-19 and diabetes mellitus: may old anti-diabetic agents become the new philosopher's stone?", "author": "Penlioglou", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "Diabetes Ther", "key": "10.1016/j.diabet.2020.07.006_bib0080", "volume": "11", "year": "2020" }, { "DOI": "10.1016/j.diabres.2020.108183", "article-title": "Metformin in COVID-19: a possible role beyond diabetes", "author": "Sharma", "doi-asserted-by": "crossref", "journal-title": "Diabetes Res Clin Pract", "key": "10.1016/j.diabet.2020.07.006_bib0085", "volume": "164", "year": "2020" }, { "article-title": "Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?", "author": "Kumar Singh", "journal-title": "Diabetes Res Clin Pract", "key": "10.1016/j.diabet.2020.07.006_bib0090", "volume": "165", "year": "2020" }, { "DOI": "10.1007/s00125-017-4342-z", "article-title": "The mechanisms of action of metformin", "author": "Rena", "doi-asserted-by": "crossref", "first-page": "1577", "journal-title": "Diabetologia", "key": "10.1016/j.diabet.2020.07.006_bib0095", "volume": "60", "year": "2017" }, { "article-title": "Metformin and COVID-19: a novel deal of an old drug", "author": "El-Arabey", "journal-title": "J Med Virol", "key": "10.1016/j.diabet.2020.07.006_bib0100", "volume": "29", "year": "2020" }, { "DOI": "10.1111/obr.13084", "article-title": "Obesity and COVID-19: the mTOR pathway as a possible culprit", "author": "Bolourian", "doi-asserted-by": "crossref", "journal-title": "Obes Rev", "key": "10.1016/j.diabet.2020.07.006_bib0105", "year": "2020" }, { "DOI": "10.3892/wasj.2020.68", "article-title": "Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review)", "author": "Lehrer", "doi-asserted-by": "crossref", "first-page": "1", "issue": "3", "journal-title": "World Acad Sci J", "key": "10.1016/j.diabet.2020.07.006_bib0110", "volume": "2", "year": "2020" }, { "article-title": "A proposed mechanism for the possible therapeutic potential of metformin in COVID-19", "author": "Esam", "journal-title": "Diabetes Res Clin Pract", "key": "10.1016/j.diabet.2020.07.006_bib0115", "volume": "164", "year": "2020" }, { "DOI": "10.1016/j.diabres.2020.108230", "article-title": "Metformin, neutrophils and COVID-19 infection", "author": "Dalan", "doi-asserted-by": "crossref", "journal-title": "Diabetes Res Clin Pract", "key": "10.1016/j.diabet.2020.07.006_bib0120", "volume": "164", "year": "2020" }, { "DOI": "10.18632/aging.103347", "article-title": "Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19", "author": "Menendez", "doi-asserted-by": "crossref", "first-page": "8760", "journal-title": "Aging (Albany NY)", "key": "10.1016/j.diabet.2020.07.006_bib0125", "volume": "12", "year": "2020" }, { "DOI": "10.1002/jmv.26090", "article-title": "Metformin use amid coronavirus disease 2019 pandemic", "author": "Kow", "doi-asserted-by": "crossref", "journal-title": "J Med Virol", "key": "10.1016/j.diabet.2020.07.006_bib0130", "year": "2020" }, { "DOI": "10.1016/j.diabres.2020.108167", "article-title": "COVID-19 and diabetes: is metformin a friend or foe?", "author": "Ursini", "doi-asserted-by": "crossref", "journal-title": "Diabetes Res Clin Pract", "key": "10.1016/j.diabet.2020.07.006_bib0135", "volume": "164", "year": "2020" }, { "DOI": "10.1016/j.diabres.2020.108184", "article-title": "Comment on “Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?.”", "author": "Cure", "doi-asserted-by": "crossref", "journal-title": "Diabetes Res Clin Pract", "key": "10.1016/j.diabet.2020.07.006_bib0140", "volume": "164", "year": "2020" }, { "article-title": "Observational study of metformin and risk of mortality in patients hospitalized with Covid-19", "author": "Bramante", "journal-title": "medRxiv", "key": "10.1016/j.diabet.2020.07.006_bib0145", "volume": "28", "year": "2020" }, { "DOI": "10.2337/dc20-0660", "article-title": "Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication", "author": "Chen", "doi-asserted-by": "crossref", "first-page": "1399", "journal-title": "Diabetes Care", "key": "10.1016/j.diabet.2020.07.006_bib0150", "volume": "43", "year": "2020" }, { "DOI": "10.4269/ajtmh.20-0375", "article-title": "Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis", "author": "Luo", "doi-asserted-by": "crossref", "first-page": "69", "journal-title": "Am J Trop Med Hyg", "key": "10.1016/j.diabet.2020.07.006_bib0155", "volume": "103", "year": "2020" }, { "DOI": "10.1016/j.cmet.2020.04.021", "article-title": "Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes", "author": "Zhu", "doi-asserted-by": "crossref", "first-page": "1068", "journal-title": "Cell Metab", "key": "10.1016/j.diabet.2020.07.006_bib0160", "volume": "31", "year": "2020" }, { "DOI": "10.1016/j.diabet.2013.02.006", "article-title": "Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes", "author": "Scheen", "doi-asserted-by": "crossref", "first-page": "179", "journal-title": "Diabetes Metab", "key": "10.1016/j.diabet.2020.07.006_bib0165", "volume": "39", "year": "2013" }, { "DOI": "10.1186/s13054-019-2346-4", "article-title": "Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies", "author": "Liang", "doi-asserted-by": "crossref", "first-page": "50", "journal-title": "Crit Care", "key": "10.1016/j.diabet.2020.07.006_bib0170", "volume": "23", "year": "2019" }, { "DOI": "10.1007/s00228-019-02786-y", "article-title": "Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis", "author": "Zhang", "doi-asserted-by": "crossref", "first-page": "149", "journal-title": "Eur J Clin Pharmacol", "key": "10.1016/j.diabet.2020.07.006_bib0175", "volume": "76", "year": "2020" }, { "DOI": "10.1016/S1262-3636(07)70261-6", "article-title": "Effect of metformin on survival rate in experimental sepsis", "author": "Gras", "doi-asserted-by": "crossref", "first-page": "147", "journal-title": "Diabetes Metab", "key": "10.1016/j.diabet.2020.07.006_bib0180", "volume": "32", "year": "2006" }, { "DOI": "10.1002/dmrr.2975", "article-title": "Is metformin poised for a second career as an antimicrobial?", "author": "Malik", "doi-asserted-by": "crossref", "first-page": "e2975", "journal-title": "Diabetes Metab Res Rev", "key": "10.1016/j.diabet.2020.07.006_bib0185", "volume": "34", "year": "2018" }, { "DOI": "10.1111/resp.13486", "article-title": "Reduced mortality from lower respiratory tract disease in adult diabetic patients treated with metformin", "author": "Mendy", "doi-asserted-by": "crossref", "first-page": "646", "journal-title": "Respirology", "key": "10.1016/j.diabet.2020.07.006_bib0190", "volume": "24", "year": "2019" }, { "DOI": "10.1186/s12931-019-1035-9", "article-title": "Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease", "author": "Ho", "doi-asserted-by": "crossref", "first-page": "69", "journal-title": "Respir Res", "key": "10.1016/j.diabet.2020.07.006_bib0195", "volume": "20", "year": "2019" }, { "DOI": "10.1111/dom.12854", "article-title": "Understanding and overcoming metformin gastrointestinal intolerance", "author": "Bonnet", "doi-asserted-by": "crossref", "first-page": "473", "journal-title": "Diabetes Obes Metab", "key": "10.1016/j.diabet.2020.07.006_bib0200", "volume": "19", "year": "2017" }, { "DOI": "10.14309/ajg.0000000000000691", "article-title": "COVID-19 and the digestive system", "author": "Ma", "doi-asserted-by": "crossref", "first-page": "1003", "journal-title": "Am J Gastroenterol", "key": "10.1016/j.diabet.2020.07.006_bib0205", "volume": "115", "year": "2020" }, { "DOI": "10.1111/dom.12974", "article-title": "Metformin-associated lactic acidosis (MALA): moving towards a new paradigm", "author": "Lalau", "doi-asserted-by": "crossref", "first-page": "1502", "journal-title": "Diabetes Obes Metab", "key": "10.1016/j.diabet.2020.07.006_bib0210", "volume": "19", "year": "2017" }, { "DOI": "10.1016/j.diabet.2020.06.003", "article-title": "SGLT2 inhibition during the COVID-19 epidemic: friend or foe?", "author": "Scheen", "doi-asserted-by": "crossref", "journal-title": "Diabetes Metab", "key": "10.1016/j.diabet.2020.07.006_bib0215", "year": "2020" }, { "DOI": "10.1016/j.diabet.2018.09.005", "article-title": "Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: potential contribution for diabetic complications and cardiovascular disease", "author": "Bonnet", "doi-asserted-by": "crossref", "first-page": "457", "journal-title": "Diabetes Metab", "key": "10.1016/j.diabet.2020.07.006_bib0220", "volume": "44", "year": "2018" } ], "reference-count": 44, "references-count": 44, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1262363620300987" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Metformin and COVID-19: From cellular mechanisms to reduced mortality", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "46" }